[English] 日本語
Yorodumi- EMDB-70826: Cryo-EM structure of the PI4KA complex bound to an EFR3 interferi... -
+
Open data
-
Basic information
| Entry | ![]() | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Title | Cryo-EM structure of the PI4KA complex bound to an EFR3 interfering nanobody (F3IN) | |||||||||||||||
Map data | Composite map | |||||||||||||||
Sample |
| |||||||||||||||
Keywords | PI4KA / TTC7B / FAM126A / Nanobody / Complex / SIGNALING PROTEIN | |||||||||||||||
| Function / homology | Function and homology informationreorganization of cellular membranes to establish viral sites of replication / Synthesis of PIPs at the ER membrane / 1-phosphatidylinositol 4-kinase / 1-phosphatidylinositol 4-kinase activity / Synthesis of PIPs at the Golgi membrane / host-mediated perturbation of viral process / Golgi-associated vesicle membrane / phosphatidylinositol biosynthetic process / phosphatidylinositol-mediated signaling / phosphatidylinositol phosphate biosynthetic process ...reorganization of cellular membranes to establish viral sites of replication / Synthesis of PIPs at the ER membrane / 1-phosphatidylinositol 4-kinase / 1-phosphatidylinositol 4-kinase activity / Synthesis of PIPs at the Golgi membrane / host-mediated perturbation of viral process / Golgi-associated vesicle membrane / phosphatidylinositol biosynthetic process / phosphatidylinositol-mediated signaling / phosphatidylinositol phosphate biosynthetic process / myelination / protein localization to plasma membrane / neuron projection / cadherin binding / focal adhesion / signal transduction / extracellular exosome / ATP binding / membrane / plasma membrane / cytosol / cytoplasm Similarity search - Function | |||||||||||||||
| Biological species | Homo sapiens (human) / ![]() | |||||||||||||||
| Method | single particle reconstruction / cryo EM / Resolution: 3.54 Å | |||||||||||||||
Authors | Shaw AL / Suresh S / Yip CK / Burke JE | |||||||||||||||
| Funding support | Canada, 4 items
| |||||||||||||||
Citation | Journal: J Biol Chem / Year: 2025Title: Development of an inhibitory TTC7B selective nanobody that blocks EFR3 recruitment of PI4KA. Authors: Sushant Suresh / Alexandria L Shaw / Damilola K Akintola / Martine Lunke / Sophia Doerr / Pooja Rohilla / Tamas Balla / Calvin K Yip / Scott D Hansen / Jennifer A Cobb / John E Burke / ![]() Abstract: Phosphatidylinositol 4 kinase IIIα (PI4KIIIα/PI4KA) is an essential lipid kinase that plays a critical role in regulating plasma membrane identity. PI4KA is primarily recruited to the plasma ...Phosphatidylinositol 4 kinase IIIα (PI4KIIIα/PI4KA) is an essential lipid kinase that plays a critical role in regulating plasma membrane identity. PI4KA is primarily recruited to the plasma membrane through the targeted recruitment by the proteins, EFR3A and EFR3B, which bind to the PI4KA accessory proteins TTC7 (TTC7A/B) and FAM126 (FAM126A/B). Here we characterised how both EFR3 isoforms interact with all possible TTC7-FAM126 combinations and developed a nanobody that specifically blocked EFR3-mediated PI4KA recruitment in TTC7B containing complexes. Most EFR3-TTC7-FAM126 combinations show similar binding affinities, with the exception of EFR3A-TTC7B-FAM126A, which binds with a ∼10-fold higher affinity. Moreover, we showed that EFR3B phosphorylation markedly decreased binding to TTC7-FAM126. Using a yeast display approach, we isolated a TTC7B selective nanobody that blocked EFR3 binding. Cryo-electron microscopy and hydrogen deuterium exchange mass spectrometry showed an extended interface with both PI4KA and TTC7B that sterically blocks EFR3 binding. The nanobody caused decreased membrane recruitment both on lipid bilayers and in cells, with decreased PM production of PI4P. Collectively, these findings provide new insights into PI4KA regulation and provide a tool for manipulating PI4KA complexes, that may be valuable for therapeutic targeting. | |||||||||||||||
| History |
|
-
Structure visualization
| Supplemental images |
|---|
-
Downloads & links
-EMDB archive
| Map data | emd_70826.map.gz | 570.1 MB | EMDB map data format | |
|---|---|---|---|---|
| Header (meta data) | emd-70826-v30.xml emd-70826.xml | 25 KB 25 KB | Display Display | EMDB header |
| Images | emd_70826.png | 112 KB | ||
| Filedesc metadata | emd-70826.cif.gz | 8.9 KB | ||
| Archive directory | http://ftp.pdbj.org/pub/emdb/structures/EMD-70826 ftp://ftp.pdbj.org/pub/emdb/structures/EMD-70826 | HTTPS FTP |
-Validation report
| Summary document | emd_70826_validation.pdf.gz | 473.8 KB | Display | EMDB validaton report |
|---|---|---|---|---|
| Full document | emd_70826_full_validation.pdf.gz | 473.4 KB | Display | |
| Data in XML | emd_70826_validation.xml.gz | 8.2 KB | Display | |
| Data in CIF | emd_70826_validation.cif.gz | 9.6 KB | Display | |
| Arichive directory | https://ftp.pdbj.org/pub/emdb/validation_reports/EMD-70826 ftp://ftp.pdbj.org/pub/emdb/validation_reports/EMD-70826 | HTTPS FTP |
-Related structure data
| Related structure data | ![]() 9ot6MC C: citing same article ( M: atomic model generated by this map |
|---|---|
| Similar structure data | Similarity search - Function & homology F&H Search |
-
Links
| EMDB pages | EMDB (EBI/PDBe) / EMDataResource |
|---|---|
| Related items in Molecule of the Month |
-
Map
| File | Download / File: emd_70826.map.gz / Format: CCP4 / Size: 669.9 MB / Type: IMAGE STORED AS FLOATING POINT NUMBER (4 BYTES) | ||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annotation | Composite map | ||||||||||||||||||||||||||||||||||||
| Projections & slices | Image control
Images are generated by Spider. | ||||||||||||||||||||||||||||||||||||
| Voxel size | X=Y=Z: 0.77 Å | ||||||||||||||||||||||||||||||||||||
| Density |
| ||||||||||||||||||||||||||||||||||||
| Symmetry | Space group: 1 | ||||||||||||||||||||||||||||||||||||
| Details | EMDB XML:
|
-Supplemental data
-
Sample components
-Entire : Dimer of heterotetramers of PI4KA,TTC7B,FAM126A, and EFR3 interfe...
| Entire | Name: Dimer of heterotetramers of PI4KA,TTC7B,FAM126A, and EFR3 interfering nanobody (F3IN) |
|---|---|
| Components |
|
-Supramolecule #1: Dimer of heterotetramers of PI4KA,TTC7B,FAM126A, and EFR3 interfe...
| Supramolecule | Name: Dimer of heterotetramers of PI4KA,TTC7B,FAM126A, and EFR3 interfering nanobody (F3IN) type: complex / ID: 1 / Parent: 0 / Macromolecule list: all |
|---|---|
| Molecular weight | Theoretical: 767 KDa |
-Supramolecule #2: PI4KA,TTC7B,FAM126A complex
| Supramolecule | Name: PI4KA,TTC7B,FAM126A complex / type: complex / ID: 2 / Parent: 1 / Macromolecule list: #1, #3-#4 |
|---|---|
| Source (natural) | Organism: Homo sapiens (human) |
-Supramolecule #3: EFR3 interfering nanobody (F3IN)
| Supramolecule | Name: EFR3 interfering nanobody (F3IN) / type: complex / ID: 3 / Parent: 1 / Macromolecule list: #2 |
|---|---|
| Source (natural) | Organism: ![]() |
-Macromolecule #1: Phosphatidylinositol 4-kinase alpha
| Macromolecule | Name: Phosphatidylinositol 4-kinase alpha / type: protein_or_peptide / ID: 1 / Number of copies: 2 / Enantiomer: LEVO / EC number: 1-phosphatidylinositol 4-kinase |
|---|---|
| Source (natural) | Organism: Homo sapiens (human) |
| Molecular weight | Theoretical: 237.246438 KDa |
| Recombinant expression | Organism: ![]() |
| Sequence | String: GSMAAAPARG GGGGGGGGGG CSGSGSSASR GFYFNTVLSL ARSLAVQRPA SLEKVQKLLC MCPVDFHGIF QLDERRRDAV IALGIFLIE SDLQHKDCVV PYLLRLLKGL PKVYWVEEST ARKGRGALPV AESFSFCLVT LLSDVAYRDP SLRDEILEVL L QVLHVLLG ...String: GSMAAAPARG GGGGGGGGGG CSGSGSSASR GFYFNTVLSL ARSLAVQRPA SLEKVQKLLC MCPVDFHGIF QLDERRRDAV IALGIFLIE SDLQHKDCVV PYLLRLLKGL PKVYWVEEST ARKGRGALPV AESFSFCLVT LLSDVAYRDP SLRDEILEVL L QVLHVLLG MCQALEIQDK EYLCKYAIPC LIGISRAFGR YSNMEESLLS KLFPKIPPHS LRVLEELEGV RRRSFNDFRS IL PSNLLTV CQEGTLKRKT SSVSSISQVS PERGMPPPSS PGGSAFHYFE ASCLPDGTAL EPEYYFSTIS SSFSVSPLFN GVT YKEFNI PLEMLRELLN LVKKIVEEAV LKSLDAIVAS VMEANPSADL YYTSFSDPLY LTMFKMLRDT LYYMKDLPTS FVKE IHDFV LEQFNTSQGE LQKILHDADR IHNELSPLKL RCQANAACVD LMVWAVKDEQ GAENLCIKLS EKLQSKTSSK VIIAH LPLL ICCLQGLGRL CERFPVVVHS VTPSLRDFLV IPSPVLVKLY KYHSQYHTVA GNDIKISVTN EHSESTLNVM SGKKSQ PSM YEQLRDIAID NICRCLKAGL TVDPVIVEAF LASLSNRLYI SQESDKDAHL IPDHTIRALG HIAVALRDTP KVMEPIL QI LQQKFCQPPS PLDVLIIDQL GCLVITGNQY IYQEVWNLFQ QISVKASSVV YSATKDYKDH GYRHCSLAVI NALANIAA N IQDEHLVDEL LMNLLELFVQ LGLEGKRASE RASEKGPALK ASSSAGNLGV LIPVIAVLTR RLPPIKEAKP RLQKLFRDF WLYSVLMGFA VEGSGLWPEE WYEGVCEIAT KSPLLTFPSK EPLRSVLQYN SAMKNDTVTP AELSELRSTI INLLDPPPEV SALINKLDF AMSTYLLSVY RLEYMRVLRS TDPDRFQVMF CYFEDKAIQK DKSGMMQCVI AVADKVFDAF LNMMADKAKT K ENEEELER HAQFLLVNFN HIHKRIRRVA DKYLSGLVDK FPHLLWSGTV LKTMLDILQT LSLSLSADIH KDQPYYDIPD AP YRITVPD TYEARESIVK DFAARCGMIL QEAMKWAPTV TKSHLQEYLN KHQNWVSGLS QHTGLAMATE SILHFAGYNK QNT TLGATQ LSERPACVKK DYSNFMASLN LRNRYAGEVY GMIRFSGTTG QMSDLNKMMV QDLHSALDRS HPQHYTQAMF KLTA MLISS KDCDPQLLHH LCWGPLRMFN EHGMETALAC WEWLLAGKDG VEVPFMREMA GAWHMTVEQK FGLFSAEIKE ADPLA ASEA SQPKPCPPEV TPHYIWIDFL VQRFEIAKYC SSDQVEIFSS LLQRSMSLNI GGAKGSMNRH VAAIGPRFKL LTLGLS LLH ADVVPNATIR NVLREKIYST AFDYFSCPPK FPTQGEKRLR EDISIMIKFW TAMFSDKKYL TASQLVPPDN QDTRSNL DI TVGSRQQATQ GWINTYPLSS GMSTISKKSG MSKKTNRGSQ LHKYYMKRRT LLLSLLATEI ERLITWYNPL SAPELELD Q AGENSVANWR SKYISLSEKQ WKDNVNLAWS ISPYLAVQLP ARFKNTEAIG NEVTRLVRLD PGAVSDVPEA IKFLVTWHT IDADAPELSH VLCWAPTDPP TGLSYFSSMY PPHPLTAQYG VKVLRSFPPD AILFYIPQIV QALRYDKMGY VREYILWAAS KSQLLAHQF IWNMKTNIYL DEEGHQKDPD IGDLLDQLVE EITGSLSGPA KDFYQREFDF FNKITNVSAI IKPYPKGDER K KACLSALS EVKVQPGCYL PSNPEAIVLD IDYKSGTPMQ SAAKAPYLAK FKVKRCGVSE LEKEGLRCRS DSEDECSTQE AD GQKISWQ AAIFKVGDDC RQDMLALQII DLFKNIFQLV GLDLFVFPYR VVATAPGCGV IECIPDCTSR DQLGRQTDFG MYD YFTRQY GDESTLAFQQ ARYNFIRSMA AYSLLLFLLQ IKDRHNGNIM LDKKGHIIHI DFGFMFESSP GGNLGWEPDI KLTD EMVMI MGGKMEATPF KWFMEMCVRG YLAVRPYMDA VVSLVTLMLD TGLPCFRGQT IKLLKHRFSP NMTEREAANF IMKVI QSCF LSNRSRTYDM IQYYQNDIPY UniProtKB: Phosphatidylinositol 4-kinase alpha |
-Macromolecule #2: EFR3 interfering Nanobody (F3IN)
| Macromolecule | Name: EFR3 interfering Nanobody (F3IN) / type: protein_or_peptide / ID: 2 / Number of copies: 2 / Enantiomer: LEVO |
|---|---|
| Source (natural) | Organism: ![]() |
| Molecular weight | Theoretical: 18.025229 KDa |
| Recombinant expression | Organism: ![]() |
| Sequence | String: MKYLLPTAAA GLLLLAAQPA MAMAQVQLQE SGGGLVQAGG SLRLSCAASG TISASDYMGW YRQAPGKERE LVASIDGGGI TNYADSVKG RFTISRDNAK NTVYLQMNSL KPEDTAVYYC AVDWILARYN FVIHYYWGQG TQVTVSSGSY PYDVPDYALE H HHHHH |
-Macromolecule #3: Tetratricopeptide repeat protein 7B
| Macromolecule | Name: Tetratricopeptide repeat protein 7B / type: protein_or_peptide / ID: 3 / Number of copies: 2 / Enantiomer: LEVO |
|---|---|
| Source (natural) | Organism: Homo sapiens (human) |
| Molecular weight | Theoretical: 94.294109 KDa |
| Recombinant expression | Organism: ![]() |
| Sequence | String: MATKKAGSRL ETEIERCRSE CQWERIPELV KQLSAKLIAN DDMAELLLGE SKLEQYLKEH PLRQGASPRG PKPQLTEVRK HLTAALDRG NLKSEFLQES NLIMAKLNYV EGDYKEALNI YARVGLDDLP LTAVPPYRLR VIAEAYATKG LCLEKLPISS S TSNLHVDR ...String: MATKKAGSRL ETEIERCRSE CQWERIPELV KQLSAKLIAN DDMAELLLGE SKLEQYLKEH PLRQGASPRG PKPQLTEVRK HLTAALDRG NLKSEFLQES NLIMAKLNYV EGDYKEALNI YARVGLDDLP LTAVPPYRLR VIAEAYATKG LCLEKLPISS S TSNLHVDR EQDVITCYEK AGDIALLYLQ EIERVILSNI QNRSPKPGPA PHDQELGFFL ETGLQRAHVL YFKNGNLTRG VG RFRELLR AVETRTTQNL RMTIARQLAE ILLRGMCEQS YWNPLEDPPC QSPLDDPLRK GANTKTYTLT RRARVYSGEN IFC PQENTE EALLLLLISE SMANRDAVLS RIPEHKSDRL ISLQSASVVY DLLTIALGRR GQYEMLSECL ERAMKFAFEE FHLW YQFAL SLMAAGKSAR AVKVLKECIR LKPDDATIPL LAAKLCMGSL HWLEEAEKFA KTVVDVGEKT SEFKAKGYLA LGLTY SLQA TDASLRGMQE VLQRKALLAF QRAHSLSPTD HQAAFYLALQ LAISRQIPEA LGYVRQALQL QGDDANSLHL LALLLS AQK HYHDALNIID MALSEYPENF ILLFSKVKLQ SLCRGPDEAL LTCKHMLQIW KSCYNLTNPS DSGRGSSLLD RTIADRR QL NTITLPDFSD PETGSVHATS VAASRVEQAL SEVASSLQSS APKQGPLHPW MTLAQIWLHA AEVYIGIGKP AEATACTQ E AANLFPMSHN VLYMRGQIAE LRGSMDEARR WYEEALAISP THVKSMQRLA LILHQLGRYS LAEKILRDAV QVNSTAHEV WNGLGEVLQA QGNDAAATEC FLTALELEAS SPAVPFTIIP RVL UniProtKB: Tetratricopeptide repeat protein 7B |
-Macromolecule #4: Hyccin
| Macromolecule | Name: Hyccin / type: protein_or_peptide / ID: 4 / Number of copies: 2 / Enantiomer: LEVO |
|---|---|
| Source (natural) | Organism: Homo sapiens (human) |
| Molecular weight | Theoretical: 34.638867 KDa |
| Recombinant expression | Organism: ![]() |
| Sequence | String: MFTSEKGVVE EWLSEFKTLP ETSLPNYATN LKDKSSLVSS LYKVIQEPQS ELLEPVCHQL FEFYRSGEEQ LLQFTLQFLP ELIWCYLAV SASRNVHSSG CIEALLLGVY NLEIVDKQGH TKVLSFTIPS LSKPSVYHEP SSIGSMALTE SALSQHGLSK V VYSGPHPQ ...String: MFTSEKGVVE EWLSEFKTLP ETSLPNYATN LKDKSSLVSS LYKVIQEPQS ELLEPVCHQL FEFYRSGEEQ LLQFTLQFLP ELIWCYLAV SASRNVHSSG CIEALLLGVY NLEIVDKQGH TKVLSFTIPS LSKPSVYHEP SSIGSMALTE SALSQHGLSK V VYSGPHPQ REMLTAQNRF EVLTFLLLCY NAALTYMPSV SLQSLCQICS RICVCGYPRQ HVRKYKGISS RIPVSSGFMV QM LTGIYFA FYNGEWDLAQ KALDDIIYRA QLELYPEPLL VANAIKASLP HGPMKSNKEG TRCIQVEITP T UniProtKB: Hyccin |
-Experimental details
-Structure determination
| Method | cryo EM |
|---|---|
Processing | single particle reconstruction |
| Aggregation state | particle |
-
Sample preparation
| Concentration | 0.75 mg/mL | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buffer | pH: 7 Component:
| |||||||||||||||
| Grid | Model: C-flat-2/1 / Material: COPPER / Mesh: 300 / Pretreatment - Type: GLOW DISCHARGE / Pretreatment - Atmosphere: AIR Details: Glow discharged using the Pelco EasiGlow. 15mA Current. | |||||||||||||||
| Vitrification | Cryogen name: ETHANE / Chamber humidity: 100 % / Chamber temperature: 277.15 K / Instrument: FEI VITROBOT MARK IV / Details: Blot force -5, blot time 1.5 s.. | |||||||||||||||
| Details | Gel filtration buffer, filtered through 0.22um filter and degassed. 0.75mg/ml of PI4KA with 3 fold molar excess F3IN Nanobody, with 0.25 mM BS3 crosslinker. |
-
Electron microscopy
| Microscope | TFS KRIOS |
|---|---|
| Specialist optics | Energy filter - Name: TFS Selectris |
| Image recording | Film or detector model: FEI FALCON III (4k x 4k) / Number grids imaged: 2 / Number real images: 14026 / Average electron dose: 50.0 e/Å2 |
| Electron beam | Acceleration voltage: 300 kV / Electron source: FIELD EMISSION GUN |
| Electron optics | Illumination mode: FLOOD BEAM / Imaging mode: BRIGHT FIELD / Nominal defocus max: 2.0 µm / Nominal defocus min: 0.5 µm / Nominal magnification: 165000 |
| Experimental equipment | ![]() Model: Titan Krios / Image courtesy: FEI Company |
Movie
Controller
About Yorodumi



Keywords
Homo sapiens (human)
Authors
Canada, 4 items
Citation








Z (Sec.)
Y (Row.)
X (Col.)






















Processing
FIELD EMISSION GUN

